|
1.
|
M VermaP PatelM VermaBiomarkers in
prostate cancer
epidemiologyCancers337733798201110.3390/cancers304377324213111
|
|
2.
|
A JemalR SiegelJ XuE WardCancer
statistics, 2010Cancer J Clin60277300201010.3322/caac.20073
|
|
3.
|
A VickersC SavageH LiljaFinasteride to
prevent prostate cancer: should all men or only a high-risk
subgroup be treated?J Clin
Oncol2811121116201010.1200/JCO.2009.23.557220124185
|
|
4.
|
MS LuciaAK DarkePJ GoodmanFG La RosaHL
ParnesLG FordCA Coltman JrIM ThompsonPathologic characteristics of
cancers detected in The Prostate Cancer Prevention Trial:
implications for prostate cancer detection and
chemopreventionCancer Prev Res
(Phila)3167173200810.1158/1940-6207.CAPR-08-007819138952
|
|
5.
|
K ShimadaM NakamuraE IshidaM KishiN
KonishiRoles of p38- and c-jun NH2-terminal kinase-mediated
pathways in 2-methoxyestradiol-induced p53 induction and
apoptosisCarcinogenesis2410671075200310.1093/carcin/bgg05812807754
|
|
6.
|
Y FanH ChenB QiaoL LuoH MaOpposing effects
of ERK and p38 MAP kinases on HeLa cell apoptosis induced by
dipyrithioneMol Cells233038200717464209
|
|
7.
|
RJ DavisSignal transduction by the JNK
group of MAP
kinasesCell103239252200010.1016/S0092-8674(00)00116-111057897
|
|
8.
|
K SabapathyK HochedlingerSY NamA BauerM
KarinE WagnerDistinct roles for JNK1 and JNK2 in regulating JNK
activity and c-Jun-dependent cell proliferationMol
Cell15713725200410.1016/j.molcel.2004.08.02815350216
|
|
9.
|
CY KuanDD YangDR SamantaJ RogerRJ DavisP
RakicRA FlavellThe Jnk1 and Jnk2 protein kinases are required for
regional specific apoptosis during early brain
developmentNeuron22667676199910.1016/S0896-6273(00)80727-810230788
|
|
10.
|
H TsuikiM TnaniI OkamotoLC
KenyonConstitutively active forms of c-Jun NH2-terminal
kinase are expressed in primary glial tumorsCancer
Res63250255200312517805
|
|
11.
|
G LiaoQ TaoM KofronJS ChenA SchloemerRJ
DavisJC HsiehC WylieJ HeasmanCY KuanJun NH2-terminal
kinase (JNK) prevents nuclear β-catenin accumulation and regulates
axis formation in Xenopus embryosProc Natl Acad Sci
USA10316313163182006
|
|
12.
|
E ParraJ FerreiraKnockdown of the
c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast
carcinoma cell lines growthOncol
Rep2413391345201010.3892/or_0000099120878129
|
|
13.
|
F BostR McKayM BostO PotapovaNM DeanD
MercolaThe Jun kinase 2 isoform is preferentially required for
epidermal growth factor-induced transformation of human A549 lung
carcinoma cellsMol Cell Biol19193819491999
|
|
14.
|
YM YangF BostW CharbonoN DeanR McKayJS
RhimC DepatieD MercolaC-Jun NH2-terminal kinase mediates
proliferation and tumor growth of human prostate carcinomaClin
Cancer Res93913982003
|
|
15.
|
J LiuA LinRole of JNK activation in
apoptosis: a double-edged swordCell
Res153642200510.1038/sj.cr.729026215686625
|
|
16.
|
NJ KennedyRJ DavisRole of JNK in tumor
developmentCell Cycle2199201200312734425
|
|
17.
|
G PearsonF RobinsonTB GibsonB XuM
KarandikarK BermanMH CobbMitogen-activated protein (MAP) kinase
pathways: regulation and physiological functionsEndocr
Rev22153183200111294822
|
|
18.
|
S ElmoreApoptosis: a review of programmed
cell deathToxicol
Pathol35495516200710.1080/0192623070132033717562483
|
|
19.
|
A AshkenaziVM DixitDeath receptors:
signaling and
modulationScience28113051308199810.1126/science.281.5381.13059721089
|
|
20.
|
FM FosterTW OwensJ Tanianis-HughesRB
ClarkeK BrennanNJ BundredCH StreuliTargeting inhibitor of apoptosis
proteins in combination with ErbB antagonists in breast
cancerBreast Cancer Res11R41200910.1186/bcr232819563669
|
|
21.
|
Y WeiT FanM YuInhibitor of apoptosis
proteins and apoptosisActa Biochim Biophys Sin
(Shanghai)40278288200810.1111/j.1745-7270.2008.00407.x18401525
|
|
22.
|
NK SahZ KhanGJ KhanPS BisenStructural,
functional and therapeutic biology of survivinCancer
Lett244164171200610.1016/j.canlet.2006.03.00716621243
|
|
23.
|
J InostrozaL SaenzG CalafG CabelloE
ParraRole of the phosphatase PP4 in the activation of JNK-1 in
prostate carcinoma cell lines PC-3 and LNCaP resulting in increased
AP-1 and EGR-1 activityBiol
Res38163178200510.4067/S0716-9760200500020000616238095
|
|
24.
|
E ParraA OrtegaL SaenzDownregulation of
Egr-1 by siRNA inhibits growth of human prostate carcinoma cell
line PC-3Oncol Rep2215131518200919885607
|
|
25.
|
E ParraJ FerreiraA OrtegaOverexpression of
EGR-1 modulates the activity of NF-κB and AP-1 in prostate
carcinoma PC-3 and LNCaP cell linesInt J
Oncol39345352201121617851
|
|
26.
|
E ParraF FerreiraL SaenzDiverse effects of
siRNA-EGR-1 on NF-κB and AP-1 transcription factors in prostate
carcinoma cell lines PC-3 and LNCaPInt J Mol Med288478532011
|
|
27.
|
OA MareninovaKF SungP HongA LugeaSJ
PandolI GukovskyAS GukovskayaCell death in pancreatitis: caspases
protect from necrotizing pancreatitisJ Biol
Chem28133703381200610.1074/jbc.M51127620016339139
|
|
28.
|
DB LongleyTR WilsonM McEwanWL AllenU
McDermottL GalliganPG Johnstonc-FLIP inhibits chemotherapy-induced
colorectal cancer cell
deathOncogene25838848200610.1038/sj.onc.120912216247474
|
|
29.
|
M KingM Radicchi-MastroianniEffects of
caspase inhibition on camptothecin-induced apoptosis of HL-60
cellsCytometry492835200210.1002/cyto.1014112210608
|
|
30.
|
YT IpRJ DavisSignal transduction by the
c-Jun N-terminal kinase (JNK) from inflamation to developmentCurr
Opin Cell Biol10205219199810.1016/S0955-0674(98)80143-99561845
|
|
31.
|
PV MejiaJM BenitoA FernándezHD HanL
MangalaC Rodríguezc-Jun-NH2-kinase-1 inhibition leads to
antitumor activity in ovarian cancerClin Cancer Res161841922010
|
|
32.
|
J LiuY MinemotoA Linc-Jun N-terminal
protein kinase 1 (JNK1), but not JNK2, is essential for tumor
necrosis factor alpha-induced c-Jun kinase activation and
apoptosisMol Cell
Biol241084410856200410.1128/MCB.24.24.10844-10856.200415572687
|
|
33.
|
LF LinczDeciphering the apoptotic pathway:
all roads lead to deathImmunol Cell
Biol761199810.1046/j.1440-1711.1998.00712.x9553771
|
|
34.
|
JM BrownLD AttardiThe role of apoptosis in
cancer development and treatment responseNat Rev
Cancer5231237200515738985
|
|
35.
|
A WicovskyN MillerN DaryabR MarienfeldC
KneitzS KavuriM LeverkusB BaumannH WajantSustained JNK activation
in response to tumor necrosis factor is mediated by caspases in a
cell type-specific mannerJ Biol
Chem28221742183200710.1074/jbc.M60616720017121845
|
|
36.
|
A MeriinVL GabaiJ YaglomJY VictorI
ShifriniMY ShermanProteasome inhibitors activate stress kinases and
induce Hsp72. Diverse effects on apoptosisJ Biol
Chem27363736379199810.1074/jbc.273.11.63739497367
|
|
37.
|
E ParraActivation of MAP kinase family
members triggered by TPA or ionomycin occurs via the protein
phosphatase 4 pathway in Jurkat leukemia T cellsMol Med
Rep5773778201222200849
|
|
38.
|
P CodognoAJ MeijerAutophagy and signaling:
their role in cell survival and cell deathCell Death
Differ1215091518200510.1038/sj.cdd.440175116247498
|
|
39.
|
M ZhaoM YangL YangY YuM XieS ZhuR KangD
TangZ JiangW YuanHMGB1 regulates autophagy through increasing
transcriptional activities of JNK and ERK in human myeloid leukemia
cellsBMB Rep44601606201110.5483/BMBRep.2011.44.9.60121944254
|
|
40.
|
BK SabapathyT KallunkiJP DavidI GraefM
KarinEF Wagnerc-Jun NH2-terminal kinase (JNK)1 and JNK2 have
similar and stage-dependent roles in regulating T cell apoptosis
and proliferationJ Exp
Med193317328200110.1084/jem.193.3.31711157052
|
|
41.
|
C DongDD YangM WyskAJ WhitmarshRJ DavisRA
FlavellDefective T cell differentiation in the absence of
JNK1Science28220922095199810.1126/science.282.5396.20929851932
|
|
42.
|
R GjersetA HaghighiS LebedevaD MercolaGene
therapy approaches to sensitization of human prostate carcinoma to
cisplatin by adenoviral expression of p53 and by antisense jun
kinase oligonucleotide methodsMethods Mol
Biol175495520200111462854
|
|
43.
|
O PotapovaA HaghighiF BostC LiuMJ BirrerR
GjersetD MercolaThe Jun kinase/stress-activated protein kinase
pathway functions to regulate DNA repair and inhibition of the
pathway sensitizes tumor cells to cisplatinJ Biol
Chem2721404114044199710.1074/jbc.272.22.140419162025
|
|
44.
|
DL PersonsEM YazlovitskayaW CulJC
PellingCisplatin-induced activation of mitogen-activated protein
kinases in ovarian carcinoma cells: inhibition of extracellular
signal-regulated kinase activity increases sensitivity to
cisplatinClin Cancer Res5100710141999
|
|
45.
|
J HayakawaM OhmichiH KurachH IkegamiA
KimuraT MatsuokaH JikiharaD MercolaY MurataInhibition of
extracellular signal-regulated protein kinase or c-Jun N-terminal
protein kinase cascade, differentially activated by cisplatin,
sensitizes human ovarian cancer cell-lineJ Biol
Chem2743164831654199910.1074/jbc.274.44.31648
|
|
46.
|
YM YangF BostW CharbonoN DeanR McKayJS
RhimC DepatieD MercolaC-Jun NH2-terminal kinase mediates
proliferation and tumor growth in human prostrate carcinomaClin
Cancer Res93914012003
|
|
47.
|
S KornblauM WombleYH QiuCE JacksonW ChenM
KonoplevaEH EsteyM AndreeffSynergistic induction of apoptosis by
simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute
myelogenous
leukemiaBlood9934613464200210.1182/blood.V99.9.346111964319
|
